Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.22 - $8.26 $313,722 - $496,426
60,100 New
60,100 $489,000
Q1 2022

May 17, 2022

BUY
$21.6 - $27.79 $12.9 Million - $16.6 Million
597,200 Added 98.99%
1,200,500 $27.4 Million
Q4 2021

Feb 15, 2022

SELL
$23.0 - $29.01 $2.73 Million - $3.45 Million
-118,900 Reduced 16.46%
603,300 $16.7 Million
Q3 2021

Nov 16, 2021

SELL
$25.04 - $30.06 $6.87 Million - $8.25 Million
-274,500 Reduced 27.54%
722,200 $20.1 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $1.49 Million - $1.78 Million
54,500 Added 5.78%
996,700 $29.2 Million
Q1 2021

May 18, 2021

BUY
$21.37 - $34.38 $4.37 Million - $7.03 Million
204,400 Added 27.7%
942,200 $29.9 Million
Q4 2020

Feb 17, 2021

BUY
$15.31 - $21.12 $639,958 - $882,816
41,800 Added 6.01%
737,800 $15.3 Million
Q3 2020

Nov 17, 2020

BUY
$14.88 - $20.13 $5 Million - $6.76 Million
335,800 Added 93.23%
696,000 $10.8 Million
Q2 2020

Aug 17, 2020

BUY
$13.31 - $20.51 $3.31 Million - $5.09 Million
248,400 Added 222.18%
360,200 $6.59 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $1.4 Million - $3.25 Million
-107,600 Reduced 49.04%
111,800 $1.73 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $510,030 - $861,030
27,000 Added 14.03%
219,400 $6.56 Million
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $1.93 Million - $2.37 Million
-92,200 Reduced 32.4%
192,400 $4.2 Million
Q2 2019

Aug 15, 2019

BUY
$20.52 - $26.45 $1.95 Million - $2.51 Million
94,800 Added 49.95%
284,600 $7.18 Million
Q1 2019

May 16, 2019

SELL
$20.23 - $26.29 $3.77 Million - $4.9 Million
-186,200 Reduced 49.52%
189,800 $4.69 Million
Q4 2018

Feb 15, 2019

BUY
$17.64 - $28.32 $4.95 Million - $7.94 Million
280,400 Added 293.31%
376,000 $6.95 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $1.97 Million - $2.45 Million
95,600 New
95,600 $2.45 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.94B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.